|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 《2020 NTCA/CDC建议:潜伏性结核感染治疗指南》摘译显示文摘美国潜伏性结核感染治疗综合指南最近一次发布是在2000年。在这之后,一些新的治疗方案已在临床试验中得到评估。为更新以前的指南,美国国家结核病控制协会(NTCA)和美国疾病控制与预防中心(CDC)成立了一个委员会,2017年12月开始对治疗潜伏性结核感染的临床试验进行系统的文献综述,对治疗潜伏性结核感染最有效、毒性最小的方案提出新的建议。该指南编写基于干预措施的利弊平衡,证据质量,患者价值观、意愿,以及可行性制定建议。最终推荐3种首选的基于利福霉素的治疗方案和2种替代性的异烟肼单药治疗方案。 | 伍玉琪 谭彩霞 吴安华 Sterling TR Njie G Zenner D | 2020 | 中国感染控制杂志2020，19，10： | 13 |
| 2 | Heat-denatured human immunodeficiency virus type 1 protein 24 antigen:prognostic value in adults with early-stage disease显示文摘 | Sterling TR Hoover DR Astemborski J | 2002 | J Infect Dis2002，186，8： | 1 |
| 3 | A systematic review of gyrase mutations associated with fl uoroquinolone-resistant Mycobaeterium tuberculosis and a proposed gyrase numbering system 显示文摘 | Maruri F Sterling TR Kaiga AW | 2012 | J Antimicrob Chemother2012，67，4： | 1 |
| 4 | Diagnosis and treatment of latent tuberculosis infection:an update 显示文摘 | Person AK Pettit AC Sterling TR | 2013 | Curr Respir Care Rep2013，2，4： | 1 |
| 5 | Threemonths of rifapentine and isoniazid for latent tuberculosisinfection显示文摘 | Sterling TR Villarino ME Borisov AS et at | 2011 | N Engl J Med2011，365，23： | 1 |
| 6 | Three months of rifapentine and isoniazid for latent tuberculosis infection显示文摘 | Sterling TR Villarino ME Borisov AS | 2011 | N Engl J Med2011，365，23： | 1 |
| 7 | Tuberculosis 显示文摘 | Frieden TR Sterling TR MunsIffSS | 2003 | Lancet2003，362，9387： | 1 |
| 8 | Diagnosis and treatment of ventilator-associated pneumonia-impact on survival显示文摘 | Sterling TR Ho EJ Brehm WT | 1996 | Chest1996，110，4： | 1 |
| 9 | The emergence of drug-resistance tuberculosis in New York city显示文摘 | Friend TR Sterling T Pablos Mendez A | 1993 | N Engl J Med1993，328，： | 1 |
| 10 | Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durabl evirologic suppression: longer follow-up of an observational cohort study显示文摘 | Sterling TR Chaisson RE Keruly J | 2003 | J Infect Dis2003，188，： | 1 |
| 11 | Tuberculosis显示文摘 | Frieden TR Sterling TR Munsiff SS | 2003 | Lancet2003，362，9387： | 1 |
| 12 | Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicity显示文摘 | Sterling TR Chaisson RE Moore RD | 2003 | Clin Infect Dis2003，36，： | 1 |
| 13 | Tuberculosis显示文摘 | Frieden TR Sterling TR Munsiff SS | 2003 | Lancet2003，362，9387： | 1 |
| 14 | Fluoroquinolone resistance in mycobacterium tuberculosis: an assessment of MGIT 960,MODS and Nitrate reductase assay and fluroquinolone cross-resistance显示文摘 | Davasia RA Blackman A May C Eden S Smith T Hooper N Maruri F Stratton C Shintani A Sterling TR | 2009 | J Antimierob Chemother2009，63，： | 1 |
| 15 | Tuberculosis显示文摘 | Frieden TR Sterling TR Munsiff SS | 2003 | Lancet2003，362，9387： | 1 |
| 16 | Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression:longer follow-up of an observational cohort study显示文摘 | Sterling TR Chaisson RE Keruly J | 2003 | J Infect Dis2003，188，11： | 1 |
| 17 | Tuberculosis显示文摘 | Frieden TR Sterling TR Munsiff SS | | 0，，9387： | 1 |
| 18 | Prescr/hing of contraindicated p rotease inhibitor and statin combinations a- mong HIV infected persons 显示文摘 | Hulgan T Sterling TR Daugherty J | 2005 | J Acquir Immune Defic Syndr2005，38，3： | 1 |
| 19 | Disgnosis and treatment of Ventilator associated pneumonia显示文摘 | Sterling TR Ho EJ Berlum WT | 1996 | Impact on Surviv Chest1996，110，4： | 1 |
| 20 | A prospective,randomized,double-blind study of the tolerability of rifapentine 600,900,and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment显示文摘 | Bock NN Sterling TR Hamilton CD | 2002 | Am J Respir Crit Care Med2002，165，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员